The role and mechanism of TRIM32 in CRC progression and metastasis are still largely unknown; however, TRIM32 may be a potential biomarker to effectively diagnose CRC and evaluate the prognosis of CRC patients in the future. The gene discussed is TRIM32; the disease is colorectal carcinoma.